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httcense.Abstract Objective: To determine the beneﬁt of DWI in diagnosis of benign and malignant solid
or predominantly solid gynecological adnexal or ovarian masses.
Material and Methods: This study is carried out on 23 patients with histologically proven solid or
predominantly solid adnexal or ovarian masses out of which 5 cases (21.8%) have benign and 18
cases (78.2%) have malignant neoplasms. Among these 19 cases (82.6%) have unilateral disease
and 4 cases (17.4%) have bilateral disease which was metastatic ovarian carcinoma.
Result: On DWI, high signal intensity is noted in malignant lesion more frequently than in benign
lesion. (P< 0.001) in adnexal lesions, while in ovarian lesions (P= 0.001).
The differentiation between benign and malignant adnexal lesions revealed no signiﬁcant difference
in the apparent diffusion coefﬁcient (ADC) value (P= 0.22).
Conclusion: DWI is a helpful tool in differentiation between predominantly solid and solid benign
and malignant adnexal lesions because there is an increased frequency of higher signal intensity (dif-
fusion restriction) in malignant lesions.
 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
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MRI plays an increasingly important role in the evaluation of
the patients with adnexal disease. Accurate tissue characteriza-
tion often allows deﬁnitive diagnosis not possible with other
imaging modalities (1). Studies have looked at the utility of
MRI in the differential diagnosis of benign and malignant le-
sions using some morphological and signal intensity features
of the lesions (2–5). The use of DWI and ADC mapping inProduction and hosting by Elsevier B.V. All rights reserved.
.12.006
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gested for the central nervous system (CNS) and the head and
neck regions (6). But over time DWI became recognized and
accepted in body imaging for detection and characterization
of focal lesion (7–11). Our goal in this study was to evaluate
the role of DWI and ADC in discrimination between benign
and malignant solid or predominantly solid adnexal or ovarian
masses.
2. Materials and methods
The study is carried out on 23 patients, collected from gyneco-
logical department in the Zagazig University Hospitals during
the period from February 2010 to February 2011. These pa-
tients are classiﬁed into two groups.
First group consists of 5 patients with pathologically proved
benign adnexal lesions. Their age ranged from 20 to 60 years.
Second group consists of 18 patients with pathologically
proved malignant adnexal lesions. Their age ranged from
30 to 70 years.
Among these 23 patients, 19 patients have unilateral lesions
and 4 cases have bilateral lesions which were metastatic ovar-
ian carcinomas. All these cases were diagnosed by transab-
dominal (TA) and transvaginal (TV) ultrasound as adnexal
masses having solid or predominantly solid lesions.
2.1. MRI Protocol
MRI machine, 1.5 Tesla with phased-array body coil.
Imaging sequences and parameters are:
Sagittal T1 – HASTE-T2 – T2-FSAT WIs.
Axial T1 – HASTE-T2 – T2-FSAT WIs.
Coronal HASTE-T2.
Axial Diffusion WI (DWI): single shot echo planar during
normal respiration. TR/TE = 7006/86; section thickness
6 mm; intersection gap 1 mm; matrix size 128 · 128; FOV
360 · 360 mm; partial Fourier factor 6/8; band width 1158, ﬁve
excitations, b0, b400, b800 with fat saturation.
Apparent Diffusion Coefﬁcient (ADC) axial image.
Sagittal – axial–coronal VIBE pre and post contrast.
2.2. Image analysis
The acquired images are transferred to a work station, on
which all ADC maps are performed. The mean ADC volume
is determined and the signal intensity of the lesions is
measured.
2.2.1. Qualitative analysis
The lesions are evaluated for signal intensity onDWI atmaximum
b value (b= 800 s/mm2), T2WI and post contrast images.
At least 3 areas of solid tissue signal changes are used in
complex masses choosing the highest signal regions to evaluate
restriction on DWI (800 s/mm2).
On DWI, the signal intensity of each lesion is evaluated as
hyper, hypo or iso-intense relative to the myometrium. Noneof our cases had hysterectomy; however, in case of hysterec-
tomy or abnormal myometrial signal we can use the pelvic
muscles as a reference but this needs further study.
On T2 WI, the signal intensity of each lesion is evaluated by
comparison with signal intensity of the outer myometrium.
On T1, post contrast image, the enhancement pattern is di-
vided into:
First group: Marked enhancement; for the lesions whose
signal intensity was equal to or higher than the
myometrium.
Second group: Mild enhancement; for the lesions with
lower signal intensity than the myometrium.
2.2.2. Quantitative analysis
The (ROI) region of interest is placed within the lesions in the
area with the Lowest ADC volume on ADC map and highest
intensity on DWI (800 s/mm2) and mean value is calculated.
For adnexal lesions, we compared benign with malignant
lesion.
For ovarian lesions we compared benign with malignant le-
sions and malignant lesions of ovarian origin with those of
metastatic origin.
2.2.3. Statistical analysis
Final diagnosis is performed by biopsy and histopathology
(Table 1).
3. Result
3.1. Adnexal lesions
3.1.1. Qualitative analysis
Fifteen cases of the total 23 cases (15 of 18 malignant lesions)
have higher signal intensity on DWI. This means that the high-
er signal intensity is noted more frequently in malignant than
in benign adnexal lesions (P< 0.001). Two cases of malignant
lesions have iso-intense signal on DWI and 1 benign lesion has
iso-intense signal on DWI (P 0.53).
Four cases of the benign lesions have hypointense signal on
DWI and 1 malignant lesion was hypointense (P 0.002).
(Table 2).
Leiomyoma had low signal intensity on DWI.
Leiomyosarcoma appears heterogenous with the main com-
ponent appearing mildly hyperintense on DWI. Eleven cases of
23 patients (11 of 18 malignant lesions) have hyperintense sig-
nal on T2 WI of its solid component (Table 3), while solid
components of benign lesions in this study show hyperintensity
on the T2 WI in only one case (excluding fat containing lesions
or cystic components). So that, hyperintense signal on T2 WI
is noted more in solid parts of the malignant lesions
(P< 0.0001). On the other hand, low signal intensity is noted
more in the solid parts of benign lesions than in malignant le-
sions (P= 0.000). On post contrast T1 WI (Table 4), 16 of the
total 23 cases (14 from 18 malignant lesions and 2 from 5 be-
nign lesions) show marked post contrast enhancement. This
means, there is a signiﬁcant difference between benign and
malignant adnexal lesions on T1 post contrast images
(P= 0.14).
Table 1 Shows the number of pathologically proven solid benign and malignant adnexal lesions,
the measured ADC range and the mean ADC value.
Lesions No. of lesions ADC (mean ± SD)
A. Benign
1. Adnexal
a. Broad ligament leiomyoma 2 0.69 ± 0.42
2. Ovarian
a. Fibroma 1 0.72
b. Struma ovarii (Fig. 1) 1 0.90
c. Fibrothecoma (Fig. 2) 1 0.85
Total 5
B. Malignant
1. Adnexal
a. Broad ligament leiomyosarcoma 1 0.86 ± 0.86
b. Papillary serous adenocarcinoma of fallopian tubes 1 1.20
2. Ovarian
a. Granulosa cell tumor (Fig. 5) 4 1 ± 0.12
b. Dysgerminoma 4 0.70 ± 0.15
c. Serous cyst adenocarcinoma (Fig. 3) 3 0.76 ± 0.1
d. Recurrent ovarian carcinoma 1 0.98
e. Metastatic ovarian carcinoma (Fig. 4) 4 0.97 ± 0.11
Total 18
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The was no signiﬁcant difference in ADC values of the benign and
malignant lesions, however, the signal intensity or DWI is higher in
malignant lesions in comparison with the benign lesions.
3.2. Ovarian lesions
There are 3 benign ovarian lesions (Figs. 1 and 2) and 16
malignant ovarian lesions (Figs. 3–5).
3.2.1. Qualitative analysis
Three benign lesions have low or iso-intense signal intensity on
DWI in comparison with malignant lesions (Figs. 1 and 2).
Fifteen of 16 malignant lesions have higher signal intensity
on DWI (Figs. 3–5). Only one malignant ovarian lesion was
iso-intense on DWI (Table 5).
This means the malignant ovarian lesions have higher sig-
nal intensity on DWI than the benign lesions (Table 5)
(P= 0.001).
Twelve of 16 malignant ovarian lesions have hyperintense
signal of its solid component on T2 WI (Table 6), while hyper-
intensity detected on T2 WI is seen only in one case of benign
ovarian lesions (struma ovarii Fig. 1).
Twelve out of 16 malignant ovarian lesions have marked T1
post-contrast enhancement (Figs. 3 and 4), while marked post
contrast T1 enhancement is detected in one case only of all be-
nign ovarian lesions (P= 0.22) (Table 7).
3.2.2. Quantitative analysis (Table 1)
There is no signiﬁcant difference in ADC value between benign
and malignant adnexal lesions (P= 0.22).
4. Discussion
DWI gives information about the biophysical properties of the
tissue, so that it is useful in body imaging as it helps in thedetection and characterization of focal lesions. On the other
hand, ADC value is related to the cellularity or cell density.
When the tissue cellularity or cell density increased, the
ADC value decreased and this might indicate malignancy with
large cell diameter and cell density which restricts water diffu-
sion. While a decrease in tissue cellularity and density results in
increased ADC value which reﬂects the benign process (9).
Nakayama et al. (7) stated that malignant and benign ovarian
cystic ﬂuids cannot be differentiated based on the ﬁndings on
EPDWI or the ADC value, according to this we use the
DWI and ADC map changes.
The result of our study shows that, there was no signiﬁcant
difference noted between benign and malignant solid adnexal
lesions on ADC value. Furthermore, the ADC values of pri-
mary malignant ovarian neoplasm, metastatic ovarian lesion
and recurrent ovarian neoplasm were overlapped.
Bakir et al (12), and Fujii et al (13), agree with our study
because they reported that ADC value did not differ signiﬁ-
cantly between benign and malignant lesions with many over-
laps between ADC values of both categories. This overlap
which was explained by Fujii et al is due to increased mean
ADC values in the malignant lesions and the decreased ADC
values in benign lesions as the desmoplastic reaction in the
stroma may cause increased mean ADC values in malignant
tumors (13).
A signiﬁcant difference in signal intensity between benign
and malignant solid adnexal lesions is noted on DWI when
compared to ADC values, high signal intensity was observed
more frequently in malignant lesions when evaluated on
DWI quantitatively or qualitatively than benign lesion.
Fujii et al, also reported that the solid malignant ovarian
tumors show high signal intensity on DWI. In our study, 15
of 16 malignant ovarian lesions demonstrated high signal
intensity on DWI, one malignant ovarian lesion was isointense
which pathologically was serous cyst adenocarcinoma, one ad-
nexal lesion was hypointense which proved pathologically to
be a broad ligament lieomyosarcoma, the other adnexal
Table 2 Shows the variation in signal intensity between the
benign and malignant solid adnexal lesions on DWI.
Signal intensity Benign lesion
(No. = 5)
Malignant lesion
(No. = 18)
P value
Hyperintensity 0 15 (83%) 0.001
Hypointensity 4 (80%) 1 (6%) 0.002
Iso-intensity 1 (20%) 2 (11%) 0.53
Table 3 Shows the signal intensities of solid component in the
benign and malignant adnexal lesions on the T2 WI.
Signal intensity Benign lesion
(No. = 5)
Malignant lesions
(No. = 18)
P value
Hyperintense 1 (20%) 11 (61%) 0.15
Hypointense 3 (60%) 1 (6%) 0.02
Iso-intense 1 (20%) 6 (33%) 1.0
Table 4 Shows the difference between the benign and
malignant adnexal lesions on T1 weighted (VIBE) post contrast
image.
Degree of enhancement Benign lesions
(No. = 5)
Malignant lesions
(No. = 18)
P value
Marked 2 (40%) 14 (78%) 0.14
Mild 3 (60%) 4 (22%) 0.14
Fig. 1 Pathologically proven struma ovarii of right ovary. (a) Corona
contrast image shows evident enhancement of the lesion. (c) DWI-
restriction. (d) ADC image with the lesion hypointense in signal.
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illary serous adenocarcinoma of fallopian tubes. Our observa-
tion was in concordance with Fujii et al. and Bakir et al, who
reported that higher signal intensity is observed in malignant
ovarian lesions than in benign lesions.
In our study, there is no signiﬁcant difference seen on DWI
between signal intensities of primary, secondary and recurrent
ovarian tumors. However, there is a signiﬁcant difference in
ADC value between primary, secondary and recurrent ovarian
tumors but there was an overlap between the two groups sug-
gesting that DWI cannot be used to differentiate primary
malignant and metastatic ovarian lesions.
We observed that the benign lesion demonstrated a hypoin-
tense signal in DWI more than malignant lesions, one case was
isointense which proved to be struma ovarii. Our observation
was in concordance with Fujii et al. and Bakir et al, who re-
ported that higher signal intensity occurred less in benign ovar-
ian lesions than in malignant lesions considering that benign
lesion in our study was less than malignant lesions.
In our study, the malignant ovarian lesions had marked
enhancement on T1 post contrast image while only one case
of the benign ovarian lesions (struma ovarii) had marked
enhancement.
In our study, the malignant adnexal and ovarian lesions
demonstrate on T2 WI higher signal intensity while benign le-
sions demonstrate low signal intensity except in one case only
(struma ovarii) which shows higher signal intensity, and the
difference was statistically signiﬁcant.
In addition, higher signal intensity on T2 WI associated
with more enhancement on post contrast T1 WI, reﬂects the
malignant nature of the lesion, while low signal intensity on
T2 WI associated with mild post contrast enhancement reﬂects
the benign nature of the lesion except in struma ovarii whichl HASTE image shows right side hyperintense lesion. (b) Axial post
b800 of the lesion shows isointense signal with no evidence of
Fig. 2 Pathologically proven ﬁbrothecoma. (a) Axial HASTE image shows globular hypointense mass in the pelvis with ascites. (b) Axial
post contrast study shows mild enhancement of the lesion. (c) DWI-b800 shows hypointense signal with no restriction. (d) ADC image
with the lesion hypointense in signal.
Fig. 3 Pathologically proved cystadenocarcinoma. (a) HASTE coronal shows mixed solid and cystic component lesion with solid parts
appearing as isointense signal. (b and c) Post contrast axial and coronal images showing enhanced solid nodular part. (d) DWI b800 shows
diffuse restriction with hyperintense signal.
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Fig. 4 Pathologically proved metastatic ovarian adenocarcinoma. (a) HASTE axial shows mainly solid bilateral ovarian lesions. (b) Post
contrast axial image shows enhanced solid parts. (c) DWIb800 shows hyperintense signal of the lesion with diffusion restriction. (d) ADC
map shows hypointense signal of solid parts of the lesion.
Fig. 5 Recurrent granulosa theca tumor. (a) Axial HASTE shows hyperintense lesion in right paramedian aspect of the upper pelvis in
case of operated granulose theca tumor. (b) axial post contrast shows heterogenous enhancement of the lesion. (c) DWI-b800 shows
hyperintense signal. (d) ADC shows hypointense signal of the lesion.
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trast enhancement. These are considered as valuable informa-
tion to help in decision making.So, in our study, most of the malignant lesions showed evi-
dence of diffusion restriction with hyperintense signal in
b= 800, hyperintense signal in T2WI with signiﬁcant post
Table 5 Shows the difference in signal intensity between
benign and malignant ovarian lesions in DWI.
Signal intensity Benign lesions
(No. = 3)
Malignant lesion
(No. = 16)
P value
Hyperintense 0 15 (94%) 0.004
Hypointense 2 (67%) 0 (0%) 0.01
Iso-intense 1 (33%) 1 (6%) 0.29
Table 6 Shows the difference in signal intensity between
benign and malignant ovarian lesions on T2 WI.
Signal intensity Benign lesions
(No. = 3)
Malignant lesion
(No. = 16)
Hyperintense 1 (33.3%) 12 (75%) 0.22
Hypointense 1 (33.3%) 0 (0%) 0.15
Iso-intense 1(33.3%) 4 (25%) 1.0
Table 7 Shows the difference in degree of enhancement on T1
post contrast image between benign and malignant ovarian
lesions.
Degree of enhancement Benign lesions
(No. = 3)
Malignant lesions
(No. = 16)
P value
Marked 1(33%) 12 (75%) 0.22
Mild 2 (67%) 4 (25%) 0.22
Can diffusion weighted imaging distinguish between benign and malignant 119contrast enhancement. While the benign lesions showed lower
signal intensity in the same b= 800 level with less signal in
T2WI and mild post contrast enhancement. ADC map was
inconclusive to differentiate the benign from malignant lesions.
5. Conclusion
Diffusion weighted image is helpful in differentiation between
benign and malignant adnexal as well as ovarian lesions, where
a higher signal intensity is observed more frequently in malig-
nant lesions. Lesions with low signal intensity on DWI with b-
value 800 or more are almost always benign, however there is
some overlap where a small number of malignant cases were
isointense and hypointense indicating that DWI is helpful
but not able to make a consistent distinction. ADC value can-
not signiﬁcantly differentiate between benign and malignant
adnexal and ovarian lesions because there is an overlap
between both. Accordingly, DWI, ADC maps are valuable se-
quences to add to the routine pelvic MRI to help differentiatethe benign from malignant lesions, aiding the surgeon’s deci-
sion and management. However, a post contrast study cannot
be replaced as it helps in the decision of vascularity and integ-
rity of the lesions.References
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